Zymeworks Q2 EPS $(0.75) Misses $(0.47) Estimate, Sales $7.00M Miss $12.36M Estimate
Portfolio Pulse from Benzinga Newsdesk
Zymeworks (NYSE:ZYME) reported Q2 losses of $(0.75) per share, missing the analyst consensus estimate of $(0.47) by 59.57%. The company also reported quarterly sales of $7.00 million, missing the analyst consensus estimate of $12.36 million by 43.35%. However, this represents an increase in losses and sales compared to the same period last year.
August 10, 2023 | 8:26 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Zymeworks reported higher than expected losses and lower than expected sales for Q2. This could negatively impact the company's stock in the short term.
Zymeworks' Q2 results were below expectations, with losses per share and sales both missing analyst estimates. This could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100